AKAN - AKANDA CORP.

0.9202
0.000   -0.022%

Share volume: 76,840
Last Updated: 03-04-2026
Pharmaceutical Products/Medicinal Chemicals: 2.32%

PREVIOUS CLOSE
CHG
CHG%
$0.92
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
-6.50%
1 Month
1.93%
3 Months
-1.88%
6 Months
-73.33%
1 Year
-42.49%
2 Year
371.90%
Key data
Stock price
$0.92
P/E Ratio 
0.00
DAY RANGE
$0.88 - $0.99
EPS 
N/A
52 WEEK RANGE
$0.42 - $9.29
52 WEEK CHANGE
-$44.23
MARKET CAP 
15.256 M
YIELD 
N/A
SHARES OUTSTANDING 
11.930 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
3.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$111,063
AVERAGE 30 VOLUME 
$114,540
Company detail
CEO: Tejinder Virk
Region: US
Website: akandacorp.com
Employees: 110
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Akanda Corp. engages in the cultivation, manufacture, and distribution of cannabis products. It intends to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Recent news